Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)

Severe alpha1-antitrypsin (AAT) deficiency predisposes to emphysema development. Highly variable rates of decline in lung function are reported in PiZZ individuals. The annual decline in forced expiratory volume in one second (FEV1; delta FEV1) was analysed in relation to smoking status in a cohort of 608 adult PiZZ individuals included in the Swedish national AAT deficiency register. Delta FEV1 was analysed in 211 never-smokers, in 351 exsmokers, and in 46 current smokers after performing at least two spirometries during a follow-up time of 1 yr or longer (median 5.5 yrs, range 1-31). The adjusted mean delta FEV1 in never-smokers was 47 mL x yr(-1) (95% confidence interval (CI) 41-53 mL x yr(-1)), 41 mL x yr(-1) (95% CI 36-48 mL x yr(-1)) in exsmokers, and 70 mL x yr(-1) (95% CI 58-82 mL x yr(-1)) in current smokers. A dose-response relationship was found between cigarette consumption and delta FEV1 in current smokers and exsmokers. In never-smokers, a greater delta FEV1 was found after 50 yrs of age than before. No sex differences were found in delta FEV1. In conclusion, among PiZZ individuals, the change in forced expiratory volume in one second is essentially the same in never-smokers and exsmokers. Smoking is associated with a dose-dependent increase in the change in forced expiratory volume in one second.

This article has been cited by other articles:

				P. J. Castaldi, D. L. DeMeo, D. M. Kent, E. J. Campbell, A. F. Barker, M. L. Brantly, E. Eden, N. G. McElvaney, S. I. Rennard, J. M. Stocks, et al. Development of Predictive Models for Airflow Obstruction in Alpha-1-Antitrypsin Deficiency Am. J. Epidemiol., October 15, 2009; 170(8): 1005 - 1013. [Abstract] [Full Text] [PDF]

				M. A. Campos, S. Alazemi, G. Zhang, M. Salathe, A. Wanner, R. A. Sandhaus, and H. Baier Clinical Characteristics of Subjects With Symptoms of {alpha}1-Antitrypsin Deficiency Older Than 60 Years Chest, March 1, 2009; 135(3): 600 - 608. [Abstract] [Full Text] [PDF]

				K Hemminki, X Li, K Sundquist, and J Sundquist Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden J Epidemiol Community Health, May 1, 2008; 62(5): 398 - 401. [Abstract] [Full Text] [PDF]

				D. K. Hogarth and G. Rachelefsky Screening and Familial Testing of Patients for {alpha}1-Antitrypsin Deficiency Chest, April 1, 2008; 133(4): 981 - 988. [Abstract] [Full Text] [PDF]

				J. B. Wilk, A. Herbert, C. M. Shoemaker, D. J. Gottlieb, and S. Karamohamed Secreted Modular Calcium-binding Protein 2 Haplotypes Are Associated with Pulmonary Function Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 554 - 560. [Abstract] [Full Text] [PDF]

				M. P. Kaczor, M. Sanak, and A. Szczeklik Rapid and Inexpensive Detection of {alpha}1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening J. Mol. Diagn., February 1, 2007; 9(1): 99 - 104. [Abstract] [Full Text] [PDF]

				L. Fregonese, H. P. A. A. van Veen, P. J. Sterk, and J. Stolk Ventilation inhomogeneity in {alpha}1-antitrypsin-deficient emphysema Eur. Respir. J., August 1, 2006; 28(2): 323 - 329. [Abstract] [Full Text] [PDF]

				D G Parr, B C Stoel, J Stolk, and R A Stockley Validation of computed tomographic lung densitometry for monitoring emphysema in {alpha}1-antitrypsin deficiency Thorax, June 1, 2006; 61(6): 485 - 490. [Abstract] [Full Text] [PDF]

				C. Strange, M. A. Moseley, Y. Jones, L. Schwarz, L. Xie, and M. L. Brantly Genetic Testing of Minors for Alpha1-Antitrypsin Deficiency Arch Pediatr Adolesc Med, May 1, 2006; 160(5): 531 - 534. [Abstract] [Full Text] [PDF]

				O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch {alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants Eur. Respir. J., November 1, 2005; 26(5): 909 - 917. [Abstract] [Full Text] [PDF]

				D A Lomas and H Parfrey {alpha}1-Antitrypsin deficiency * 4: Molecular pathophysiology Thorax, June 1, 2004; 59(6): 529 - 535. [Abstract] [Full Text] [PDF]

				M Needham and R A Stockley {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history Thorax, May 1, 2004; 59(5): 441 - 445. [Abstract] [Full Text] [PDF]

				J Stolk, W H Ng, M E Bakker, J H C Reiber, K F Rabe, H Putter, and B C Stoel Correlation between annual change in health status and computer tomography derived lung density in subjects with {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1027 - 1030. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				H. Parfrey, R. Mahadeva, N. A. Ravenhill, A. Zhou, T. R. Dafforn, R. C. Foreman, and D. A. Lomas Targeting a Surface Cavity of {alpha}1-Antitrypsin to Prevent Conformational Disease J. Biol. Chem., August 29, 2003; 278(35): 33060 - 33066. [Abstract] [Full Text] [PDF]

				E. Piitulainen, J. Areberg, M. Linden, S. Eriksson, S. Mattsson, and P. Wollmer Nutritional Status and Muscle Strength in Patients With Emphysema and Severe {alpha}1-Antitrypsin Deficiency Chest, October 1, 2002; 122(4): 1240 - 1246. [Abstract] [Full Text] [PDF]

				I S Woolhouse, D L Bayley, and R A Stockley Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of {alpha}1-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 Thorax, August 1, 2002; 57(8): 709 - 714. [Abstract] [Full Text] [PDF]

				A J Sandford and E K Silverman Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction Thorax, August 1, 2002; 57(8): 736 - 741. [Abstract] [Full Text] [PDF]

				J. S. Parmar, R. Mahadeva, B. J. Reed, N. Farahi, K. A. Cadwallader, M. T. Keogan, D. Bilton, E. R. Chilvers, and D. A. Lomas Polymers of alpha 1-Antitrypsin Are Chemotactic for Human Neutrophils . A New Paradigm for the Pathogenesis of Emphysema Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 723 - 730. [Abstract] [Full Text] [PDF]

				R. W. Carrell and D. A. Lomas Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases N. Engl. J. Med., January 3, 2002; 346(1): 45 - 53. [Full Text] [PDF]

				S. C. McCLOSKEY, B. D. PATEL, S. J. HINCHLIFFE, E. D. REID, N. J. WAREHAM, and D. A. LOMAS Siblings of Patients With Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1419 - 1424. [Abstract] [Full Text] [PDF]

				A. S. MAYER, J. K. STOLLER, B. B. BARTELSON, A. JAMES RUTTENBER, R. A. SANDHAUS, and L. S. NEWMAN Occupational Exposure Risks in Individuals with PI*Z alpha 1-Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 553 - 558. [Abstract] [Full Text] [PDF]